PortfoliosLab logoPortfoliosLab logo
MEDP vs. RACE
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

MEDP vs. RACE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and Ferrari N.V. (RACE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MEDP vs. RACE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MEDP
Medpace Holdings, Inc.
-14.50%69.05%8.38%44.31%-2.40%56.35%65.60%58.81%45.97%0.53%
RACE
Ferrari N.V.
-8.42%-11.65%26.34%59.12%-16.68%13.32%39.71%67.87%-4.47%81.95%

Fundamentals

Market Cap

MEDP:

$13.91B

RACE:

$60.14B

EPS

MEDP:

$15.23

RACE:

$8.97

PE Ratio

MEDP:

31.52

RACE:

37.73

PEG Ratio

MEDP:

0.95

RACE:

1.95

PS Ratio

MEDP:

5.62

RACE:

8.44

PB Ratio

MEDP:

30.30

RACE:

15.91

Total Revenue (TTM)

MEDP:

$2.53B

RACE:

$7.15B

Gross Profit (TTM)

MEDP:

$760.62M

RACE:

$3.69B

EBITDA (TTM)

MEDP:

$541.22M

RACE:

$2.55B

Returns By Period

In the year-to-date period, MEDP achieves a -14.50% return, which is significantly lower than RACE's -8.42% return.


MEDP

1D
4.32%
1M
6.29%
YTD
-14.50%
6M
-6.61%
1Y
57.60%
3Y*
36.68%
5Y*
23.13%
10Y*

RACE

1D
3.44%
1M
-10.92%
YTD
-8.42%
6M
-30.25%
1Y
-19.66%
3Y*
8.75%
5Y*
11.12%
10Y*
24.53%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MEDP vs. RACE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP
MEDP Risk / Return Rank: 7777
Overall Rank
MEDP Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 8282
Sortino Ratio Rank
MEDP Omega Ratio Rank: 8282
Omega Ratio Rank
MEDP Calmar Ratio Rank: 7474
Calmar Ratio Rank
MEDP Martin Ratio Rank: 7777
Martin Ratio Rank

RACE
RACE Risk / Return Rank: 2121
Overall Rank
RACE Sharpe Ratio Rank: 1717
Sharpe Ratio Rank
RACE Sortino Ratio Rank: 1818
Sortino Ratio Rank
RACE Omega Ratio Rank: 1717
Omega Ratio Rank
RACE Calmar Ratio Rank: 2626
Calmar Ratio Rank
RACE Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDP vs. RACE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and Ferrari N.V. (RACE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MEDPRACEDifference

Sharpe ratio

Return per unit of total volatility

0.85

-0.58

+1.43

Sortino ratio

Return per unit of downside risk

2.18

-0.61

+2.80

Omega ratio

Gain probability vs. loss probability

1.30

0.91

+0.39

Calmar ratio

Return relative to maximum drawdown

1.63

-0.51

+2.14

Martin ratio

Return relative to average drawdown

4.82

-0.98

+5.80

MEDP vs. RACE - Sharpe Ratio Comparison

The current MEDP Sharpe Ratio is 0.85, which is higher than the RACE Sharpe Ratio of -0.58. The chart below compares the historical Sharpe Ratios of MEDP and RACE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MEDPRACEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.85

-0.58

+1.43

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.46

0.39

+0.07

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.84

Sharpe Ratio (All Time)

Calculated using the full available price history

0.70

0.66

+0.04

Correlation

The correlation between MEDP and RACE is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

MEDP vs. RACE - Dividend Comparison

MEDP has not paid dividends to shareholders, while RACE's dividend yield for the trailing twelve months is around 2.02%.


TTM2025202420232022202120202019201820172016
MEDP
Medpace Holdings, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RACE
Ferrari N.V.
2.02%1.85%0.61%0.59%0.69%0.40%0.54%0.70%0.88%0.61%0.79%

Drawdowns

MEDP vs. RACE - Drawdown Comparison

The maximum MEDP drawdown since its inception was -42.87%, roughly equal to the maximum RACE drawdown of -43.61%. Use the drawdown chart below to compare losses from any high point for MEDP and RACE.


Loading graphics...

Drawdown Indicators


MEDPRACEDifference

Max Drawdown

Largest peak-to-trough decline

-42.87%

-43.61%

+0.74%

Max Drawdown (1Y)

Largest decline over 1 year

-32.96%

-39.22%

+6.26%

Max Drawdown (5Y)

Largest decline over 5 years

-42.87%

-39.22%

-3.65%

Max Drawdown (10Y)

Largest decline over 10 years

-39.22%

Current Drawdown

Current decline from peak

-22.62%

-34.62%

+12.00%

Average Drawdown

Average peak-to-trough decline

-12.64%

-10.61%

-2.03%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.14%

20.48%

-9.34%

Volatility

MEDP vs. RACE - Volatility Comparison

Medpace Holdings, Inc. (MEDP) has a higher volatility of 11.00% compared to Ferrari N.V. (RACE) at 9.30%. This indicates that MEDP's price experiences larger fluctuations and is considered to be riskier than RACE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MEDPRACEDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.00%

9.30%

+1.70%

Volatility (6M)

Calculated over the trailing 6-month period

29.67%

27.42%

+2.25%

Volatility (1Y)

Calculated over the trailing 1-year period

67.80%

34.06%

+33.74%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

50.92%

29.04%

+21.88%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.58%

29.35%

+20.23%

Financials

MEDP vs. RACE - Financials Comparison

This section allows you to compare key financial metrics between Medpace Holdings, Inc. and Ferrari N.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
708.45M
1.80B
(MEDP) Total Revenue
(RACE) Total Revenue
Values in USD except per share items

MEDP vs. RACE - Profitability Comparison

The chart below illustrates the profitability comparison between Medpace Holdings, Inc. and Ferrari N.V. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%35.0%40.0%45.0%50.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
29.0%
51.9%
Portfolio components
MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported a gross profit of 205.32M and revenue of 708.45M. Therefore, the gross margin over that period was 29.0%.

RACE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Ferrari N.V. reported a gross profit of 935.00M and revenue of 1.80B. Therefore, the gross margin over that period was 51.9%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported an operating income of 153.27M and revenue of 708.45M, resulting in an operating margin of 21.6%.

RACE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Ferrari N.V. reported an operating income of 513.00M and revenue of 1.80B, resulting in an operating margin of 28.5%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Medpace Holdings, Inc. reported a net income of 135.13M and revenue of 708.45M, resulting in a net margin of 19.1%.

RACE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Ferrari N.V. reported a net income of 381.00M and revenue of 1.80B, resulting in a net margin of 21.1%.